Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS

Area of Science:

• Pulmonary Medicine
• Immunology
• Cell Biology

Background:

• Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe conditions characterized by alveolar-capillary barrier disruption.
• Programmed cell death, including apoptosis, pyroptosis, necroptosis, and PANoptosis, plays a dual role in ALI/ARDS, contributing to both homeostasis and pathology.
• Excessive cell death can exacerbate lung tissue damage, highlighting the need to understand these pathways in disease.

Purpose of the Study:

• To review recent advancements in understanding PANoptosis in the context of ALI/ARDS.
• To provide a framework for developing targeted therapies for ALI/ARDS.
• To explore the role of the PANoptosome complex in lung injury.

Main Methods:

• Literature review of programmed cell death mechanisms in ALI/ARDS.
• Analysis of the role of PANoptosis and the PANoptosome complex.
• Synthesis of current research on therapeutic interventions targeting cell death pathways.

Main Results:

• PANoptosis is identified as a critical lytic inflammatory cell death pathway in ALI/ARDS.
• The PANoptosome complex is a central driver of PANoptosis in lung injury.
• Modulation of cell death pathways, particularly PANoptosis, presents therapeutic potential.

Conclusions:

• Understanding PANoptosis is crucial for developing effective treatments for ALI/ARDS.
• Targeting the PANoptosis axis offers a promising strategy for preventing and treating lung injury.
• Further research into PANoptosis mechanisms can guide the development of novel drugs.